Safety and cardiac chronotropic responsiveness to the early injection of atropine during dobutamine stress echocardiography in the elderly

Heart

Volumn 91, Issue 12, 2005, Pages 1563-1567

  Tsutsui, Jeane M ^a   Lario, F Cerqueira ^a   Fernandas, D R ^a   Kowatsch, I ^a   Sbano, J C ^a   Ramires, J A Franchini ^a   Mathias, W ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOBUTAMINE; METOPROLOL;

AGED; ANGINA PECTORIS; ARTICLE; BRADYCARDIA; CHRONOTROPISM; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; STRESS ECHOCARDIOGRAPHY; SUPRAVENTRICULAR PREMATURE BEAT; THORAX PAIN;

AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ATROPINE; CARDIOTONIC AGENTS; CORONARY ARTERIOSCLEROSIS; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEART RATE; HUMANS; HYPERTENSION; HYPOTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 28144453909     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.054445     Document Type: Article

References (25)

1. Chaitman BR, Bourassa MG, Davis K, et al. Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation 1981;64:360-7.
2. Coodley EL. Clinical spectrum and diagnostic techniques of coronary heart disease in the elderly. J Am Geriatr Soc 1988;36:447-56.
3. Poldermans D, Fioretti PM, Boersma E, et al. Dobutamine-atropine stress echocardiography in elderly patients unable to perform an exercise test: hemodynamic characteristics, safety, and prognostic value. Arch Intern Med 1994;154:2681-6.
4. Hiro J, Hiro T, Reid CL, et al. Safety and results of dobutamine stress echocardiography in women versus men and in patients older and younger than 75 years of age. Am J Cardiol 1997;80:1014-20.
5. Anthopoulos LP, Bonou MS, Kardaras FG, et al. Stress echocardiography in elderly patients with coronary artery disease: applicability, safety and prognostic value of dobutamine and adenosine echocardiography in elderly patients. J Am Coll Cardiol 1996;28:52-9.
6. Lewandowski TJ, Armstrong WF, Bach DS. Reduced test time by early identification of patients requiring atropine during dobutamine stress echocardiography. J Am Soc Echocardiogr 1998;11:236-42.
7. Lessick J, Mutlak D, Rinkevich D, et al. Prospective study of early atropine use in dobutamine stress echocardiography. Eur J Echocardiogr 2000;1:257-62.
8. Tsutsui JM, Osorio AF, Lario FA, et al. Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echocardiography with the conventional protocol. Am J Cardiol 2004;94:1367-72.
9. Kendall MJ, Woods KL, Wilkins MR, et al. Responsiveness to beta-adrenergic receptor stimulation: the effects of age are cardioselective. Br J Clin Pharmacol 1982;14:821-6.
10. Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979;26:181-6.
11. Van Brummelen P, Buhler FR, Kiowski W, et al. Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci (Land) 1981;60:571-7.
12. Poldermans D, Boersma E, Fioretti PM, et al. Cardiac chronotropic responsiveness to beta-adrenoceptor stimulation is not reduced in the elderly. J Am Coll Cardiol 1995;25:995-9.
13. Armstrong WF, Pellikka PA, Ryan T, et al. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998;11:97-104.
14. Elhendy A, van Domburg RT, Bax JJ, et al. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly. Chest 2000;117:649-56.
15. Picano E, Mathias W Jr, Pingitore A, et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 1994;344:1190-2.
16. Becher H, Chambers J, Fox K, et al. BSE procedure guidelines for the clinical application of stress echocardiography, recommendations for performance and interpretation of stress echocardiography: a report of the British Society of Echocardiography Policy Committee. Heart 2004;90(suppl 6):vi23-30.
17. Marcovitz PA, Bach DS, Mathias W, et al. Paradoxic hypotension during dobutamine stress echocardiography: clinical and diagnostic implications. J Am Coll Cardiol 1993;21:1080-6.
18. Fioretti PM, Poldermans D, Salustri A, et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J 1994;15:355-60.
19. Marwick T. Performance of stress echocardiography. In: Marwick T, eds. Stress echocardiography. Its role in the diagnosis and evaluation of coronary artery disease, 2nd ed. Dordrecht: Kluwer Academic Publishers Group, 2003:1-42.
20. Mayuga R, Arrington CT, O'Connor FC, et al. Why do exercise-induced ventricular arrhythmias increase with age? Role of M-mode echocardiographic aging changes. J Gerontol A Biol Sci Med Sci 1996;51:M23-8.
21. Lipsitz LA. Abnormalities in blood pressure homeostasis that contribute to falls in the elderly. Clin Geriatr Med 1985;1:637-48.
22. Rosamond TL, Vacek JL, Hurwitz A, et al. Hypotension during dobutamine stress echocardiography: initial description and clinical relevance. Am Heart J 1992;123:403-7.
23. Mathias W Jr, Arruda A, Santos FC, et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr 1999;12:785-91.
24. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 1997;29:1234-40.
25. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacologic basis of therapeutics. New York: McGraw-Hill, 2001:167-73.